Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 18Recruiting 5Active not recruiting 4Terminated 2Not yet recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5

Conditions

Glioblastoma 45Neuroblastoma 16Glioma 16Brain Neoplasms 14Astrocytoma 10Neoplasms 8Rhabdomyosarcoma 7Sarcoma, Ewing 6Recurrence 5Oligodendroglioma 5Medulloblastoma 5Sarcoma 4Osteosarcoma 4Melanoma 4Small Cell Lung Carcinoma 3Neuroendocrine Tumors 3Neuroectodermal Tumors, Primitive 3Lymphoma 3Gliosarcoma 3Diffuse Intrinsic Pontine Glioma 3Wilms Tumor 2Rhabdoid Tumor 2Pyloric Stenosis, Hypertrophic 2Ovarian Neoplasms 2Neoplasm Metastasis 2Ganglioneuroblastoma 2Fallopian Tube Neoplasms 2Ependymoma 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2

Interventions

Cyclophosphamide 6Temozolomide 5Etoposide 5Vincristine 3Radiotherapy 3Cisplatin 3lutetium Lu 177 dotatate 2etoposide phosphate 2Radiation 2Filgrastim 2Celecoxib 2Carboplatin 2sodium thiosulfate 1ribociclib 1pegfilgrastim 1palbociclib 1olaparib 1ibrutinib 1fludarabine 1fenofibric acid 1abemaciclib 1Topotecan 1Thiotepa 1Thalidomide 1Tamoxifen 1Tablets 1Standard of Care 1Specimen Handling 1Platinum 1ONC206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Medulloblastoma × Temozolomide × Clear all
NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT06942039 2026-02-27

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

C17 Council

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNS

Medulloblastoma, Neuroblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Pyloric Stenosis, Hypertrophic

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting
232 enrolled
CNS

Ependymoma, Medulloblastoma, Recurrence

NCT05106296 2026-01-09

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Augusta University

Phase 1 Recruiting
37 enrolled
CNS

Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT04501718 2024-10-15

Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children

Beijing Sanbo Brain Hospital

Phase 2 Recruiting
44 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡